| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| vda-1102 | hexokinase-2 | NA | Clinical trial target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Actinic keratosis[MeSHID:D055623] |
NA | phase 2 | unknown |
| vda-1102 | tissue kallikrein | NA | Clinical trial target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Actinic keratosis[MeSHID:D055623] |
NA | phase 2 | unknown |
| vda-1102 | voltage-dependent anion-selective channel 1 | NA | Clinical trial target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Actinic keratosis[MeSHID:D055623] |
NA | phase 2 | unknown |
| click here to return to the previous page | ||||||||